Pseudoepidemic of Q fever at an animal research facility

Lisa A Conti1, Thomas R Belcuore, William L Nicholson

  • 1Florida Department of Health, Tallahassee, Florida, USA. lisa_conti@doh.state.fl.us

Insights

A commercial lab

Area of Science:

  • Veterinary Medicine
  • Infectious Diseases
  • Public Health

Background:

  • A commercial laboratory reported a high Coxiella burnetii seroprevalence (75%) in individuals exposed to sheep at a research facility.
  • This finding suggested a potential outbreak of Q fever, a zoonotic disease.
  • Concerns were raised regarding laboratory quality control and accurate diagnostic testing.

Purpose of the Study:

  • To investigate the accuracy of the commercial laboratory's Coxiella burnetii testing.
  • To determine the true seroprevalence of Coxiella burnetii in the exposed population.
  • To identify the source of discrepancy and implement corrective actions.

Main Methods:

  • Retrospective analysis of serum samples initially tested by a commercial laboratory.
  • Re-testing of samples using an in-house CDC assay and the same commercial test kits at CDC.
  • Interviews with individuals to assess exposure history and compatible illness.

Main Results:

  • The commercial laboratory's initial results were found to be misinterpreted, leading to an inflated seroprevalence.
  • Corrected analysis revealed a true Coxiella burnetii seroprevalence of 27%.
  • Only the attending veterinarian was confirmed as a Q fever case, indicating a pseudoepidemic.

Conclusions:

  • A lapse in laboratory quality control caused a pseudoepidemic of Q fever.
  • Standardization and improved review of laboratory procedures are crucial for accurate diagnostic testing.
  • Enhanced public health communication and risk reduction protocols were implemented at the facility.